ONCO
Onconetix Inc
NASDAQ: ONCO · HEALTHCARE · BIOTECHNOLOGY
$0.64
-8.57% today
Updated 2026-05-01
Market cap
$514220.00
P/E ratio
—
P/S ratio
0.63x
EPS (TTM)
$-82.80
Dividend yield
—
52W range
$1 – $54
Volume
9.4M
Onconetix Inc (ONCO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $6.08M | $4.81M | $3.08M | $26.31M | $87.52M | $28.18M |
| Cash & equivalents | $6.05M | $4.31M | $1.93M | $25.75M | $4.55M | $646500.00 |
| Current assets | $6.06M | $4.60M | $3.07M | $26.26M | $5.84M | $950267.00 |
| Total liabilities | $82621.00 | $78310.00 | $1.64M | $3.92M | $86.11M | $18.57M |
| Current liabilities | $75762.00 | $68668.00 | $1.64M | $3.92M | $17.19M | $18.29M |
| Long-term debt | — | — | — | — | $118857.00 | — |
| Shareholder equity | $6.00M | $4.73M | $1.45M | $22.39M | $-5.60M | $9.61M |
| Retained earnings | $-939870.00 | $-2.54M | $-5.96M | $-19.38M | $-56.79M | $-115.68M |
| Accounts receivable | $8330.00 | $44805.00 | $152524.00 | $35850.00 | $149731.00 | $96308.00 |
| Inventory | — | $-35000.00 | $757646.00 | $0.00 | $364052.00 | $64079.00 |
| Goodwill | — | — | — | $0.00 | $55.68M | $27.05M |